Full Text View
Tabular View
Study Results
Related Studies
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
This study has been completed.
Study NCT01235897   Information provided by University of California, San Francisco

First Received on November 4, 2010.   Last Updated on March 27, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial